4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with proadifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castonguay, A; Charest, M; Rossignol, G | 1 |
| Castonguay, A; Donnelly, PJ; Massey, TE; Petsikas, D; Reid, KR; Smith, GB | 1 |
2 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and proadifen
| Article | Year |
|---|---|
In vitro and in vivo modulation of the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in hamster lung tissues.
Topics: Animals; Biotransformation; Carcinogens; Cells, Cultured; Cricetinae; Kinetics; Lung; Male; Mesocricetus; Methylcholanthrene; Nitrosamines; Organ Culture Techniques; Oxidation-Reduction; Phenobarbital; Proadifen; Protein Binding; Proteins; Reference Values | 1989 |
Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.
Topics: Aged; Biotransformation; Carcinogens; Female; Humans; Hydroxylation; Inactivation, Metabolic; Lung; Lung Neoplasms; Macrophages, Alveolar; Male; Middle Aged; Nitrosamines; Oxidation-Reduction; Proadifen; Pulmonary Alveoli | 1999 |